Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer makes appointment to its oncology business unit

This article was originally published in Scrip

Executive Summary

Pfizerhas named Dr Mace Rothenberg senior vice-president of clinical development and medical affairs for its oncology business unit. He will be responsible for overseeing clinical R&D activities, as well as postmarketing evaluation and monitoring for all oncology products. Dr Rothenberg joins from Vanderbilt, where he was professor of medicine at the Vanderbilt University Medical Center and Ingram professor of cancer research at the Vanderbilt-Ingram Cancer Center.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts